{
    "Trade/Device Name(s)": [
        "NoFact VIII Deficient Plasma"
    ],
    "Submitter Information": "r2 Diagnostics, Inc.",
    "510(k) Number": "K102851",
    "Predicate Device Reference 510(k) Number(s)": [
        "K892859"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GJT"
    ],
    "Summary Letter Date": "December 7, 2011",
    "Summary Letter Received Date": "December 8, 2011",
    "Submission Date": "November 15, 2010",
    "Regulation Number(s)": [
        "21CFR864.7290"
    ],
    "Regulation Name(s)": [
        "Factor deficiency test"
    ],
    "Analyte Class(es)": [
        "hematology",
        "coagulation"
    ],
    "Analyte(s)": [
        "Factor VIII activity"
    ],
    "Specimen Type(s)": [
        "Citrated plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "STA Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Activated partial thromboplastin time (APTT) assay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for NoFact VIII Deficient Plasma, a human plasma reagent immunodepleted of Factor VIII for quantitative determination of Factor VIII activity using APTT.",
    "Indications for Use Summary": "Intended for the quantitative determination of Factor VIII activity in citrated plasma from patients suspected of FVIII deficiency; for in vitro diagnostic use.",
    "fda_folder": "Hematology"
}